According to the Next Day Disclosure Return dated 2 December 2025, DINGDANG HEALTH TECHNOLOGY GROUP LTD. (09886) maintained a total of 1,319,472,897 issued shares. The company carried out a series of repurchases for cancellation from 25 November to 2 December 2025, involving a combined 1,249,000 shares. The repurchase prices ranged between approximately HKD 1.051 and HKD 1.0888 based on recorded transactions, representing about 0.094659% of the number of issued shares authorized for the repurchase mandate dated 28 May 2025.
The company reported that the final repurchase took place on 2 December 2025 with 277,000 shares at prices between HKD 1.06 and HKD 1.1, for an aggregate price of HKD 300,212.6. The resulting moratorium period on issuing new shares or transferring treasury shares extends until 2 January 2026, in accordance with the relevant regulations. The disclosure confirmed that all repurchases adhered to applicable listing rules and that no changes occurred in the total number of shares in issue.
Comments